Skip to main content
SpringerLink
Log in

Sarcopenic Obesity

  • Reference work entry
  • First Online:
Metabolic Syndrome

  • 265 Accesses

Abstract

An aging population in conjunction with a worsening obesity epidemic worldwide is leading to a public health epidemic of older adults with considerable mobility and functional limitations. Sarcopenia is the age-related progression of decreased muscle mass, strength, and function. Though sarcopenia naturally occurs as part of the aging process, it can be exacerbated when coupled with obesity. Older adults with sarcopenic obesity are thought to have a synergistic risk of adverse outcomes compared to those with either sarcopenia or obesity alone. Consensus groups continue their efforts in creating standardized terms and definitions for identifying those at risk for sarcopenic obesity. The standardization of definitions is critically important in developing clinical trials for sarcopenic obesity that will lead to improvement in body composition and physical function. Multicomponent management strategies consisting of physical exercise and dietary modifications are safely recommended to mitigate worsening sarcopenia, preserve muscle strength, and promote weight loss. Promising, novel therapies have the potential to improve body composition and muscle physiology in this subgroup of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Roberts AW, Ogunwole SU, Blakeslee L, Rabe MA. The population 65 years and older in the United States: 2016. American Community Survey Reports. Vol ACS-38. United States Census Bureau 2018.

    Google Scholar 

  2. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–76.

    Article  PubMed  Google Scholar 

  3. Dunlop DD, Hughes SL, Manheim LM. Disability in activities of daily living: patterns of change and a hierarchy of disability. Am J Public Health. 1997;87(3):378–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA. Cardiovascular health study collaborative research G. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.

    Article  CAS  PubMed  Google Scholar 

  5. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):E1–E25.

    Google Scholar 

  6. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist. 1969;9(3):179–86.

    Article  CAS  PubMed  Google Scholar 

  7. Chambers BA, Guo SS, Siervogel R, Hall G, Chumlea WC. Cumulative effects of cardiovascular disease risk factors on quality of life. J Nutr Health Aging. 2002;6(3):179–84.

    CAS  PubMed  Google Scholar 

  8. Rosemann T, Grol R, Herman K, Wensing M, Szecsenyi J. Association between obesity, quality of life, physical activity and health service utilization in primary care patients with osteoarthritis. Int J Behav Nutr Phys Act. 2008;5:4.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Health TfAs. State of obesity 2022. Better policies for a healthy America 2022.

    Google Scholar 

  10. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–48.

    Article  CAS  PubMed  Google Scholar 

  11. Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, Ma B. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr. 2021;40(7):4633–41.

    Article  PubMed  Google Scholar 

  12. Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34(5):791–9.

    Article  CAS  Google Scholar 

  13. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–69.

    Article  PubMed  Google Scholar 

  14. Houston DK, Ding J, Nicklas BJ, Harris TB, Lee JS, Nevitt MC, Rubin SM, Tylavsky FA, Kritchevsky SB, Health ABCS. Overweight and obesity over the adult life course and incident mobility limitation in older adults: the health, aging and body composition study. Am J Epidemiol. 2009;169(8):927–36.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zizza CA, Herring A, Stevens J, Popkin BM. Obesity affects nursing-care facility admission among whites but not blacks. Obes Res. 2002;10(8):816–23.

    Article  PubMed  Google Scholar 

  16. Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiologic reviews. 2012;35:51.

    Article  PubMed  Google Scholar 

  17. Batsis JA, Sahakyan KR, Rodriguez-Escudero JP, Bartels SJ, Lopez-Jimenez F. Normal weight obesity and functional outcomes in older adults. Eur J Intern Med. 2014;25(6):517–22.

    Article  PubMed  Google Scholar 

  18. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, Narayan KM, Williamson DF. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293(15):1868–74.

    Article  CAS  PubMed  Google Scholar 

  19. Ambrose NL, Keogan F, O’Callaghan JP, O’Connell PG. Obesity and disability in the symptomatic Irish knee osteoarthritis population. Ir J Med Sci. 2010;179(2):265–8.

    Article  CAS  PubMed  Google Scholar 

  20. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study C. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (Clin Res ed). 2007;335(7630):1134.

    Article  Google Scholar 

  21. Hassing LB, Dahl AK, Thorvaldsson V, Berg S, Gatz M, Pedersen NL, Johansson B. Overweight in midlife and risk of dementia: a 40-year follow-up study. Int J Obes. 2009;33(8):893–8.

    Article  CAS  Google Scholar 

  22. Lopez-Jimenez F, Batsis JA, Roger VL, Brekke L, Ting HH, Somers VK. Trends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004. Circ Cardiovasc Qual Outcomes. 2009;2(5):443–50.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ward ZJ, Willett WC, Hu FB, Pacheco LS, Long MW, Gortmaker SL. Excess mortality associated with elevated body weight in the USA by state and demographic subgroup: a modelling study. eClinicalMedicine. 2022;48:101429.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Sorkin JD, Muller DC, Andres R. Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore longitudinal study of aging. Am J Epidemiol. 1999;150(9):969–77.

    Article  CAS  PubMed  Google Scholar 

  25. Williamson DF. Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med. 1993;119(7 Pt 2):646–9.

    Article  CAS  PubMed  Google Scholar 

  26. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854.: World Health Organization:1–452.

    Google Scholar 

  27. Kuk JL, Ardern CI. Influence of age on the association between various measures of obesity and all-cause mortality. J Am Geriatr Soc. 2009;57(11):2077–84.

    Article  PubMed  Google Scholar 

  28. Batsis JA, Sahakyan KR, Rodriguez-Escudero JP, Bartels SJ, Somers VK, Lopez-Jimenez F. Normal weight obesity and mortality in United States subjects >/=60 years of age (from the third National Health and nutrition examination survey). Am J Cardiol. 2013;112(10):1592–8.

    Article  PubMed  Google Scholar 

  29. Batsis JA, Zhbelik AJ, Scherer E, Barre LK, Bartels S. Normal weight central obesity, physical activity, and functional decline: data from the osteoarthritis initiative. Journal of the American Geriatrics Society. 2015;63(8):1552–60.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Morley JE, Anker SD, Evans WJ. Cachexia and aging: an update based on the fourth international cachexia meeting. J Nutr Health Aging. 2009;13(1):47–55.

    Article  CAS  PubMed  Google Scholar 

  32. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C. The developmental origins of sarcopenia. J Nutr Health Aging. 2008;12(7):427–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Warming L, Hassager C, Christiansen C. Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporos Int. 2002;13(2):105–12.

    Article  CAS  PubMed  Google Scholar 

  34. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and nutrition examination survey 1999-2004. J Am Geriatr Soc. 2013;61(6):974–80.

    Article  PubMed  Google Scholar 

  36. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.

    Article  PubMed  Google Scholar 

  37. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, Ferrucci L, Guralnik JM, Fragala MS, Kenny AM, Kiel DP, Kritchevsky SB, Shardell MD, Dam TT, Vassileva MT. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.

    Article  PubMed  PubMed Central  Google Scholar 

  38. RR ML, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB, Kenny AM, Peters KW, Ferrucci L, Guralnik JM, Kritchevsky SB, Kiel DP, Vassileva MT, Xue QL, Perera S, Studenski SA, Dam TT. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014;69(5):576–83.

    Article  Google Scholar 

  39. Dam TT, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, Shardell M, Alley DE, Kenny A, Ferrucci L, Guralnik J, Kiel DP, Kritchevsky S, Vassileva MT, Studenski S. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69(5):584–90.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Cawthon PM, Peters KW, Shardell MD, McLean RR, Dam TT, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Vassileva MT, Studenski SA, Alley DE. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):567–75.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. Gait speed and survival in older adults. JAMA. 2011;305(1):50–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, Magaziner JM, Newman AB, Kiel DP, Cooper C, Guralnik JM, Cauley JA, Arai H, Clark BC, Landi F, Schaap LA, Pereira SL, Rooks D, Woo J, Woodhouse LJ, Binder E, Brown T, Shardell M, Xue QL, DʼAgostino RB, Orwig D, Gorsicki G, Correa-De-Araujo R, Cawthon PM. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020;68(7):1410–8.

    Article  PubMed  Google Scholar 

  43. Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014;11(3):177–80.

    PubMed  PubMed Central  Google Scholar 

  44. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–5.

    Article  PubMed  Google Scholar 

  45. Cawthon PM, Visser M, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S, Binder E, Bruyère O, Cederholm T, Chen L-K, Cooper C, Duque G, Fielding RA, Guralnik J, Kiel DP, Kirk B, Landi F, Sayer AA, Von Haehling S, Woo J, Cruz-Jentoft AJ. Defining terms commonly used in sarcopenia research: a glossary proposed by the global leadership in sarcopenia (GLIS) steering committee. Eur Geriat Med. 2022;13(6):1239–44.

    Article  Google Scholar 

  46. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, Boirie Y, Cruz-Jentoft AJ, Dicker D, Frara S, Frühbeck G, Genton L, Gepner Y, Giustina A, Gonzalez MC, Han HS, Heymsfield SB, Higashiguchi T, Laviano A, Lenzi A, Nyulasi I, Parrinello E, Poggiogalle E, Prado CM, Salvador J, Rolland Y, Santini F, Serlie MJ, Shi H, Sieber CC, Siervo M, Vettor R, Villareal DT, Volkert D, Yu J, Zamboni M, Barazzoni R. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr. 2022;41(4):990–1000.

    Article  CAS  PubMed  Google Scholar 

  47. Donini M, Lorenzo BL, Bischoff C, Stephan CT, Ballesteros-Pomar D, Maria BA, John BM, Juergen BY, Cruz-Jentoft J, Alfonso DD, Frara S, Frühbeck G, Genton L, Gepner Y, Giustina A, Gonzalez C, Maria HH-S, Heymsfield B, Steven HT, Laviano A, Lenzi A, Nyulasi I, Parrinello E, Poggiogalle E, Prado M, Carla SJ, Rolland Y, Santini F, Serlie J, Mireille SH, Sieber C, Cornel SM, Vettor R, Villareal T, Dennis VD, Yu J, Zamboni M, Barazzoni R. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obesity Facts. 2022;15(3):321–35.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Poggiogalle E, Lubrano C, Sergi G, Coin A, Gnessi L, Mariani S, Lenzi A, Donini LM. Sarcopenic obesity and metabolic syndrome in adult Caucasian subjects. J Nutr Health Aging. 2016;20(9):958–63.

    Article  CAS  PubMed  Google Scholar 

  49. Poggiogalle E, Lubrano C, Gnessi L, Mariani S, Di Martino M, Catalano C, Lenzi A, Donini LM. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity. Clin Nutr. 2019;38(5):2430–5.

    Article  PubMed  Google Scholar 

  50. Alizadeh PH. Exercise therapy for people with sarcopenic obesity: myokines and adipokines as effective actors. Front Endocrinol (Lausanne). 2022;13:811751.

    Article  Google Scholar 

  51. Villareal DT, Banks M, Siener C, Sinacore DR, Klein S. Physical frailty and body composition in obese elderly men and women. Obes Res. 2004;12(6):913–20.

    Article  PubMed  Google Scholar 

  52. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693–700.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Hamrick MW, Herberg S, Arounleut P, He HZ, Shiver A, Qi RQ, Zhou L, Isales CM, Mi QS. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun. 2010;400(3):379–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol. 2010;7(1):22–9.

    Article  CAS  PubMed  Google Scholar 

  55. Waters DL, Qualls CR, Dorin RI, Veldhuis JD, Baumgartner RN. Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes. J Gerontol A Biol Sci Med Sci. 2008;63(5):536–41.

    Article  PubMed  Google Scholar 

  56. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, Ferrucci L. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (Bethesda, MD : 1985). 2007;102(3):919–25.

    Article  Google Scholar 

  57. Kob R, Bollheimer LC, Bertsch T, Fellner C, Djukic M, Sieber CC, Fischer BE. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? Biogerontology. 2015;16(1):15–29.

    Article  CAS  PubMed  Google Scholar 

  58. Chang CI, Huang KC, Chan DC, Wu CH, Lin CC, Hsiung CA, Hsu CC, Chen CY. The impacts of sarcopenia and obesity on physical performance in the elderly. Obes Res Clin Pract. 2014;9:256–65.

    Article  PubMed  Google Scholar 

  59. Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/obesity and physical capacity in older men and women: data from the nutrition as a determinant of successful aging (NuAge)-the Quebec longitudinal study. Obesity. 2009;17(11):2082–8.

    Article  PubMed  Google Scholar 

  60. Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc. 2002;50(11):1802–9.

    Article  PubMed  Google Scholar 

  61. Auyeung TW, Lee JS, Leung J, Kwok T, Woo J. Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults – an alternative measurement of sarcopenia and sarcopenic obesity. Age (Dordr). 2013;35(4):1377–85.

    Article  CAS  PubMed  Google Scholar 

  62. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–63.

    Article  CAS  PubMed  Google Scholar 

  63. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12(12):1995–2004.

    Article  PubMed  Google Scholar 

  64. Rolland Y, Lauwers-Cances V, Cristini C, Abellan van Kan G, Janssen I, Morley JE, Vellas B. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) study. Am J Clin Nutr. 2009;89(6):1895–900.

    Article  CAS  PubMed  Google Scholar 

  65. Levine ME, Crimmins EM. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity (Silver Spring, MD). 2012;20(10):2101–6.

    Article  CAS  PubMed  Google Scholar 

  66. Sternfeld B, Ngo L, Satariano WA, Tager IB. Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am J Epidemiol. 2002;156(2):110–21.

    Article  PubMed  Google Scholar 

  67. Lee S, Kim TN, Kim SH. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study. Arthritis Rheum. 2012;64(12):3947–54.

    Article  PubMed  Google Scholar 

  68. Baek SJ, Nam GE, Han KD, Choi SW, Jung SW, Bok AR, Kim YH, Lee KS, Han BD, Kim DH. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and nutrition examination survey. J Endocrinol Investig. 2014;37(3):247–60.

    Article  CAS  Google Scholar 

  69. Kim TN, Yang SJ, Yoo HJ, Lim KI, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes. 2009;33(8):885–92.

    Article  CAS  Google Scholar 

  70. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Lim JY, Park KS, Jang HC. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean longitudinal study on Health and aging (KLoSHA). Diabetes Care. 2010;33(7):1652–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kim TN, Park MS, Ryu JY, Choi HY, Hong HC, Yoo HJ, Kang HJ, Song W, Park SW, Baik SH, Newman AB, Choi KM. Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic obesity study (KSOS). PLoS One. 2014;9(12):e115407.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009;13(5):460–6.

    Article  CAS  PubMed  Google Scholar 

  73. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and nutrition examination survey III. Eur J Clin Nutr. 2014;68(9):1001–7.

    Article  CAS  PubMed  Google Scholar 

  74. Atkins JL, Wannamathee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr. 2020;124(10):1102–13.

    Article  CAS  PubMed  Google Scholar 

  75. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253–60.

    Article  PubMed  Google Scholar 

  76. Beavers KM, Beavers DP, Nesbit BA, Ambrosius WT, Marsh AP, Nicklas BJ, Rejeski WJ. Effect of an 18-month physical activity and weight loss intervention on body composition in overweight and obese older adults. Obesity (Silver Spring, MD). 2014;22(2):325–31.

    Article  PubMed  Google Scholar 

  77. Shea MK, Houston DK, Nicklas BJ, Messier SP, Davis CC, Miller ME, Harris TB, Kitzman DW, Kennedy K, Kritchevsky SB. The effect of randomization to weight loss on total mortality in older overweight and obese adults: the ADAPT study. J Gerontol A Biol Sci Med Sci. 2010;65(5):519–25.

    Article  PubMed  Google Scholar 

  78. Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, Napoli N, Qualls C, Shah K. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364(13):1218–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Kritchevsky SB, Beavers KM, Miller ME, Shea MK, Houston DK, Kitzman DW, Nicklas BJ. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS One. 2015;10(3):e0121993.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Batsis JA, Huyck KL, Bartels SJ. Challenges with the medicare obesity benefit: practical concerns & proposed solutions. J Gen Intern Med. 2014;30:118.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14(9):513–37.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Verreijen AM, Engberink MF, Memelink RG, Van Der Plas SE, Visser M, Weijs PJM. Effect of a high protein diet and/or resistance exercise on the preservation of fat free mass during weight loss in overweight and obese older adults: a randomized controlled trial. Nutr J. 2017;16(1)

    Google Scholar 

  83. Trouwborst I, Verreijen A, Memelink R, Massanet P, Boirie Y, Weijs P, Tieland M. Exercise and nutrition strategies to counteract Sarcopenic obesity. Nutrients. 2018;10(5):605.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.

    Article  CAS  PubMed  Google Scholar 

  85. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92(6):2058–65.

    Article  CAS  PubMed  Google Scholar 

  86. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91–100.

    Article  CAS  PubMed  Google Scholar 

  87. Poggiogalle E, Parrinello E, Barazzoni R, Busetto L, Donini LM. Therapeutic strategies for sarcopenic obesity: a systematic review. Curr Opin Clin Nutr Metab Care. 2021;24(1):33–41.

    Article  CAS  PubMed  Google Scholar 

  88. American Geriatrics Society Workgroup on Vitamin DSfOA. Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc. 2014;62(1):147–52.

    Article  Google Scholar 

  89. Behre HM, Tammela TL, Arver S, Tolra JR, Bonifacio V, Lamche M, Kelly J, Hiemeyer F, European Testogel Study T, Giltay EJ, Gooren LJ. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male. 2012;15(4):198–207.

    Article  CAS  PubMed  Google Scholar 

  90. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, Aleman A, Lock TM, Bosch JL, Grobbee DE, van der Schouw YT. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA. 2008;299(1):39–52.

    Article  CAS  PubMed  Google Scholar 

  91. Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM, Team ACTGPAS. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab. 2007;92(3):1049–57.

    Article  CAS  PubMed  Google Scholar 

  92. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, Agrwal N, Elamin MB, Gallegos-Orozco JF, Wang AT, Erwin PJ, Bhasin S, Montori VM. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95(6):2560–75.

    Article  CAS  PubMed  Google Scholar 

  93. Xu L, Freeman G, Cowling BJ, Schooling CM. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med. 2013;11:108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Nair KS, Rizza RA, O’Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355(16):1647–59.

    Article  CAS  PubMed  Google Scholar 

  95. Baker WL, Karan S, Kenny AM. Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review. J Am Geriatr Soc. 2011;59(6):997–1002.

    Article  PubMed  Google Scholar 

  96. Konopka AR, Laurin JL, Schoenberg HM, Reid JJ, Castor WM, Wolff CA, Musci RV, Safairad OD, Linden MA, Biela LM, Bailey SM, Hamilton KL, Miller BF. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019;18(1):e12880.

    Article  PubMed  Google Scholar 

  97. Justice JN, Ferrucci L, Newman AB, Aroda VR, Bahnson JL, Divers J, Espeland MA, Marcovina S, Pollak MN, Kritchevsky SB, Barzilai N, Kuchel GA. A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME biomarkers workgroup. Geroscience. 2018;40(5–6):419–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Perna S, Guido D, Bologna C, Solerte SB, Guerriero F, Isu A, Rondanelli M. Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study. Aging Clin Exp Res. 2016;28(6):1251–7.

    Article  PubMed  Google Scholar 

  99. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA

    Danae C. Gross, Ray Cheever & John A. Batsis

  2. Division of Geriatric Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC, USA

    John A. Batsis

  3. Center for Aging and Health, University of North Carolina, Chapel Hill, NC, USA

    John A. Batsis

Authors
  1. Danae C. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ray Cheever
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John A. Batsis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John A. Batsis .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA

    Rexford S. Ahima

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gross, D.C., Cheever, R., Batsis, J.A. (2023). Sarcopenic Obesity. In: Ahima, R.S. (eds) Metabolic Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-031-40116-9_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-40116-9_38

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-40115-2

  • Online ISBN: 978-3-031-40116-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation